Embecta Corp. (EMBC): Cash & Equivalents

Annual figures by period end, from SEC filings.

$225.50M
As of 2025-09-30
$214.70M
As of 2026-06-30
-12.0%
3-year compound annual growth
$330.90M2021-09-30: $02022-09-30: $330.90M2023-09-30: $326.30M2024-09-30: $267.50M2025-09-30: $225.50M$225.50M
2021-09-30 Cash & Equivalents (USD) 2025-09-30
Period endedCash & EquivalentsChange YoYSource filing
2025-09-30$225.50M-15.7%2025-11-25, Balance as of period end
2024-09-30$267.50M-18.0%2025-11-25, Balance as of period end
2023-09-30$326.30M-1.4%2024-12-11, Balance as of period end
2022-09-30$330.90Mn/a2023-11-29, Balance as of period end
2021-09-30$0n/a2022-12-22, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Embecta Corp. (EMBC)2025-09-30$225.50M-15.7%
Tandem Diabetes Care Inc (TNDM)2025-12-31$90.63M+30.9%
Inspire Medical Systems, Inc. (INSP)2025-12-31$104.81M-30.2%
Haemonetics Corp (HAE)2026-03-28$245.44M-20.0%
Penumbra Inc (PEN)2025-12-31$186.90M-42.4%
Orthofix Medical Inc. (OFIX)2025-12-31$82.03M-1.5%
Merit Medical Systems Inc (MMSI)2025-12-31$446.40M+18.5%
Alphatec Holdings, Inc. (ATEC)2025-12-31$160.81M+15.8%
iRhythm Holdings, Inc. (IRTC)2025-12-31$236.01M-43.8%

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗